Bloom Burton & Co. Upgrades Aurinia Pharmaceuticals (AUPH) to Accumulate (2)
Tweet
Share
E-mailGet Alerts AUPH Hot Sheet
Price: $15.47 +1.91%
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Bloom Burton & Co. analyst David Martin upgraded Aurinia Pharmaceuticals (NASDAQ: AUPH) from Hold (3) to Accumulate (2) with a price target of $8.00.
For an analyst ratings summary and ratings history on Aurinia Pharmaceuticals click here. For more ratings news on Aurinia Pharmaceuticals click here.
Shares of Aurinia Pharmaceuticals closed at $5.17 yesterday.
You May Also Be Interested In
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
- JPMorgan Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Desjardins Upgrades PRO REIT (PRV-U:CN) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
